The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats

Epilepsy Research
Rafael J TamargoJohn J Aryanpur

Abstract

An alternative strategy for the treatment of intractable seizures may be to administer anticonvulsants directly into the brain near the site of a seizure focus using controlled-release polymers. We describe the pharmacokinetics of a phenytoin-ethylene-vinyl acetate (EVAc) controlled-release polymer and report the reduction of seizures in a cobalt-induced rat model of epilepsy with the intracerebral delivery of phenytoin using surgically implanted polymers. In the pharmacokinetics study, the drug release rate of 50%-loaded phenytoin-EVAc polymers (n=3) was determined in vitro over 15 weeks initially and then several months later (over a 2-week period after 1 year of in vivo release). In the efficacy study, 85 rats underwent implantation of skull-mounted cortical electrodes for electrocorticography (ECoG) and then underwent application of cobalt chloride to the cerebral cortex for the induction of seizures. Rats in the treatment group (n=9) underwent surgical implantation of phenytoin-EVAc polymers and rats in the control group (n=10) underwent implantation of empty EVAc polymers. In the morbidity study, the potential histologic pathology of the intracerebral delivery of increasing doses of phenytoin from the polymer (10, 20, 30,...Continue Reading

References

Sep 28, 1990·Science·R Langer
Feb 1, 1989·Journal of Biomedical Materials Research·R J TamargoH Brem
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Dec 1, 1982·Neurology·E RodinS Chayasirisobohn
Mar 1, 1981·Journal of Biomedical Materials Research·R LangerD Tapper
Aug 1, 1996·Acta Neurologica Scandinavica·M Dam
Apr 17, 1998·European Journal of Pharmacology·W Löscher

❮ Previous
Next ❯

Citations

Mar 9, 2004·Brain Research. Brain Research Reviews·Karen E Nilsen, Hannah R Cock
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Juan A Barcia, José M Gallego
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Michael A Rogawski
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Margaret F Bennewitz, W Mark Saltzman
Feb 28, 2008·Nature Clinical Practice. Neurology·William C Stacey, Brian Litt
Oct 24, 2013·BioMed Research International·Dirk-Matthias AltenmüllerJosef Zentner
May 9, 2012·Advanced Drug Delivery Reviews·Amy J HallidayMark J Cook
Nov 22, 2011·International Journal of Pharmaceutics·Parawee RattanakitGordon G Wallace
Dec 29, 2015·Journal of Chemical Neuroanatomy·V NatchimuthuS Ravi
Oct 21, 2015·Restorative Neurology and Neuroscience·Jonathan L JiangMark J Cook
Jul 29, 2015·Seizure : the Journal of the British Epilepsy Association·Michael P RassnerThomas M Freiman
Nov 7, 2012·Medical Hypotheses·John G Kral, Nandor Ludvig
Jun 9, 2016·Pharmaceutical Development and Technology·Thiresen GovenderViness Pillay
Feb 23, 2018·Expert Opinion on Drug Delivery·Zahraa S Al-Ahmady
Sep 1, 2018·Expert Opinion on Drug Delivery·Gilles Sebastiaan van TienderenGordon G Wallace
Mar 15, 2006·Expert Review of Neurotherapeutics·Patrick Kwan, Martin J Brodie
Jul 1, 2011·Neurosurgery·Faisal A Al-OtaibiAndres M Lozano
Aug 19, 2017·International Journal of Aging & Human Development·Pnina Dolberg, Liat Ayalon
Oct 24, 2019·Pharmaceutical Development and Technology·Zahra MohtashamiHamid Akbari Javar
Dec 2, 2020·Pharmaceutics·Manuela Gernert, Malte Feja

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.